Opportunity Information: Apply for RFA AG 22 010
This National Institutes of Health (NIH) funding opportunity (RFA-AG-22-010) supports the development and delivery of short, focused training courses that strengthen interdisciplinary behavioral and social science research related to Alzheimer's disease and related dementias (AD/ADRD). It uses the R25 education grant mechanism and is explicitly designated as "Clinical Trial Not Allowed," meaning the supported activities should center on education and research training rather than running clinical trials. The National Institute on Aging (NIA) is using this announcement to build capacity in targeted, high-priority methods and topic areas where better-trained researchers and more cross-disciplinary collaboration could meaningfully improve AD/ADRD research and, ultimately, health care and population outcomes.
The core purpose is to fund short courses that advance skills and knowledge in three specific priority areas identified by NIA. The first area is cross-national dementia research that uses harmonized data on cognitive function, emphasizing the ability to compare and integrate measures across countries and studies in ways that support rigorous international and comparative research. The second area focuses on behavioral economics approaches aimed at improving AD/ADRD health care delivery at the organizational level, which points to practical, systems-oriented research and interventions informed by behavioral economics that can change provider, clinic, or health system behavior and performance (rather than only individual patient behavior). The third area supports integrating machine learning with the social sciences to improve health care research in AD/ADRD, encouraging training that bridges computational methods with social and behavioral theory to better analyze complex health care data, predict outcomes, and evaluate services and policies relevant to dementia.
Eligible applicants are broad and include many types of U.S.-based organizations and governmental entities. Examples listed include state, county, and city or township governments; special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; federally recognized Native American tribal governments; tribal organizations that are not federally recognized; public housing authorities and Indian housing authorities; nonprofits (both 501(c)(3) and non-501(c)(3), as long as they are not institutions of higher education in those categories); for-profit organizations other than small businesses; and small businesses. The announcement also highlights additional eligible applicants such as Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISISs), Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), Tribally Controlled Colleges and Universities (TCCUs), faith-based or community-based organizations, regional organizations, eligible federal agencies, and U.S. territories or possessions. At the same time, it clearly restricts foreign involvement: non-U.S. (foreign) institutions are not eligible to apply, non-domestic components of U.S. organizations are not eligible, and foreign components (as defined by NIH policy) are not permitted.
From an administrative standpoint, this is a discretionary grant opportunity in the health category, tied to CFDA 93.866, and administered by NIH/NIA. The original application closing date listed is October 4, 2021, and the opportunity was created on March 23, 2021. The listed award ceiling is $139,000, indicating the maximum amount that could be awarded under this announcement (with actual budgets depending on the approved course structure and costs). Overall, the FOA is best read as an effort to rapidly expand the field's training infrastructure in a few carefully chosen, methodologically demanding areas that NIA views as especially important for moving AD/ADRD behavioral and social science research forward.Apply for RFA AG 22 010
- The National Institutes of Health in the health sector is offering a public funding opportunity titled "Short Courses on Interdisciplinary Behavioral and Social Sciences Research on Alzheimer's Disease and Related Dementias (R25 - Clinical Trial Not Allowed)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.866.
- This funding opportunity was created on 2021-03-23.
- Applicants must submit their applications by 2021-10-04. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Each selected applicant is eligible to receive up to $139,000.00 in funding.
- Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Frequently Asked Questions (FAQs)
What is this funding opportunity?
This is a National Institutes of Health (NIH) funding opportunity announcement (FOA) from the National Institute on Aging (NIA): RFA-AG-22-010. It supports the development and delivery of short, focused training courses intended to strengthen interdisciplinary behavioral and social science research related to Alzheimer's disease and related dementias (AD/ADRD).
What grant mechanism does it use?
The FOA uses the NIH R25 education grant mechanism. The supported work is centered on education and research training activities delivered through short courses.
Are clinical trials allowed under this FOA?
No. The FOA is explicitly designated as "Clinical Trial Not Allowed." Supported activities should focus on education and research training rather than running clinical trials.
What is the main goal of the program?
The goal is to build capacity in targeted, high-priority methods and topic areas where better-trained researchers and more cross-disciplinary collaboration could meaningfully improve AD/ADRD research and, ultimately, health care and population outcomes.
What types of activities are being funded?
The FOA funds the development and delivery of short, focused training courses. These courses are intended to advance skills and knowledge in specific priority areas identified by NIA for AD/ADRD behavioral and social science research.
What are the three NIA priority areas for the short courses?
The FOA identifies three specific training priorities:
- Cross-national dementia research using harmonized data on cognitive function, emphasizing comparison and integration of cognitive measures across countries and studies for rigorous international and comparative research.
- Behavioral economics approaches to improve AD/ADRD health care delivery at the organizational level, emphasizing practical, systems-oriented work aimed at changing provider, clinic, or health system behavior and performance (not just individual patient behavior).
- Integrating machine learning with the social sciences to improve health care research in AD/ADRD, encouraging training that bridges computational methods with social and behavioral theory to analyze complex health care data, predict outcomes, and evaluate services and policies relevant to dementia.
What does "cross-national dementia research using harmonized data" mean in this FOA?
It refers to training that helps researchers use and compare cognitive function measures across different countries and studies, with an emphasis on harmonized data and methods that support rigorous international and comparative dementia research.
What does "organizational level" mean for the behavioral economics priority area?
In this FOA, the organizational level focus means approaches informed by behavioral economics that aim to improve health care delivery by influencing provider, clinic, or health system behavior and performance, rather than focusing only on changing individual patient behavior.
What does it mean to integrate machine learning with the social sciences for AD/ADRD health care research?
It means training that connects computational methods (machine learning) with social and behavioral science theory to better study health care data related to AD/ADRD, including analyzing complex datasets, predicting outcomes, and evaluating services and policies relevant to dementia.
Who is administering this opportunity?
The opportunity is administered by NIH, specifically the National Institute on Aging (NIA).
What is the CFDA number associated with this opportunity?
The FOA is tied to CFDA 93.866.
What category of grant is this listed under?
It is described as a discretionary grant opportunity in the health category.
Who is eligible to apply?
Eligibility is broad and includes many U.S.-based organizations and governmental entities. Examples explicitly listed include:
- State governments
- County governments
- City or township governments
- Special district governments
- Independent school districts
- Public and state-controlled institutions of higher education
- Private institutions of higher education
- Federally recognized Native American tribal governments
- Tribal organizations (not federally recognized)
- Public housing authorities and Indian housing authorities
- Nonprofits (501(c)(3) and non-501(c)(3), as long as they are not institutions of higher education in those categories)
- For-profit organizations other than small businesses
- Small businesses
Are specific institution types highlighted as eligible?
Yes. The FOA highlights additional eligible applicants, including:
- Alaska Native and Native Hawaiian Serving Institutions
- Asian American Native American Pacific Islander Serving Institutions (AANAPISISs)
- Hispanic-serving Institutions
- Historically Black Colleges and Universities (HBCUs)
- Tribally Controlled Colleges and Universities (TCCUs)
- Faith-based or community-based organizations
- Regional organizations
- Eligible federal agencies
- U.S. territories or possessions
Can a non-U.S. (foreign) institution apply?
No. Non-U.S. (foreign) institutions are not eligible to apply under this FOA.
Can a U.S. organization include a non-domestic component in the application?
No. Non-domestic components of U.S. organizations are not eligible under this FOA.
Are foreign components permitted if they are part of an otherwise U.S.-based application?
No. Foreign components (as defined by NIH policy) are not permitted.
What is the maximum award amount?
The listed award ceiling is $139,000. This indicates the maximum amount that could be awarded under the announcement, with actual budgets depending on the approved course structure and costs.
When was this funding opportunity created?
The opportunity was created on March 23, 2021.
What is the original application closing date listed?
The original application closing date listed is October 4, 2021.
How should applicants think about budgeting under this FOA?
Based on the information provided, the award ceiling is $139,000, and actual budgets may vary depending on the approved short-course structure and associated costs. The FOA frames the work as course development and delivery under an R25 education mechanism.
What kind of training does NIA appear to be trying to expand through this FOA?
The FOA reads as an effort to rapidly expand AD/ADRD behavioral and social science training infrastructure in a small number of carefully chosen areas that are methodologically demanding and likely to benefit from stronger interdisciplinary collaboration.
Does the FOA emphasize interdisciplinary work?
Yes. It specifically aims to strengthen interdisciplinary behavioral and social science research related to AD/ADRD and encourages cross-disciplinary collaboration, especially in the identified priority areas.
Is the focus on research projects or training?
The focus is on education and research training delivered through short courses, not on conducting clinical trials.
Browse more opportunities from the same category: Health
Next opportunity: Novel Tools and Devices for Animal Research Facilities and to Support Care of Animal Models (R41/R42 Clinical Trial Not Allowed)
Previous opportunity: National Coastal Wetlands Conservation Grant Program
Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for RFA AG 22 010
Applicants also applied for:
Applicants who have applied for this opportunity (RFA AG 22 010) also looked into and applied for these:
| Funding Opportunity |
|---|
| Short Courses on Interdisciplinary Behavioral and Social Sciences Research on Aging (R25 - Clinical Trial Not Allowed) Apply for RFA AG 22 009 Funding Number: RFA AG 22 009 Agency: National Institutes of Health Category: Health Funding Amount: $139,000 |
| Limited Competition: Alzheimers Disease Sequencing Project Follow-Up Study 2.0 (ADSP FUS 2.0): The Diverse Population Initiative (U01 Clinical Trial Not Allowed) Apply for PAR 21 212 Funding Number: PAR 21 212 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Neural Mechanisms of Force-Based Manipulations: High Priority Research Networks (U24 Clinical Trial Optional) Apply for RFA AT 21 006 Funding Number: RFA AT 21 006 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NHGRI Predoctoral to Postdoctoral Transition Award for a Diverse Genomics Workforce (F99/K00) Apply for PAR 21 143 Funding Number: PAR 21 143 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Transformative Research to Address Health Disparities and Advance Health Equity at Minority Serving Institutions (U01 Clinical Trial Allowed) Apply for RFA RM 21 022 Funding Number: RFA RM 21 022 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Transformative Research to Address Health Disparities and Advance Health Equity (U01 Clinical Trial Allowed) Apply for RFA RM 21 021 Funding Number: RFA RM 21 021 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Transformative Nucleic Acid Sequencing Technology Innovation and Early Development (R21 Clinical Trial Not Allowed) Apply for RFA HG 21 007 Funding Number: RFA HG 21 007 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Mechanisms of HIV Resistance to Broadly Neutralizing Antibodies (bNAbs) (U01 Clinical Trial Not Allowed) Apply for RFA AI 21 009 Funding Number: RFA AI 21 009 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Transformative Nucleic Acid Sequencing Technology Innovation and Early Development (R01 Clinical Trial Not Allowed) Apply for RFA HG 21 006 Funding Number: RFA HG 21 006 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Transformative Nucleic Acid Sequencing Technology Innovation and Early Development (R43/R44) Apply for RFA HG 21 008 Funding Number: RFA HG 21 008 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Understanding Post-Transcriptional Regulation of Intact and Defective HIV RNA (R61/R33 Clinical Trial Not Allowed) Apply for RFA AI 21 012 Funding Number: RFA AI 21 012 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NIDCD's Mentoring Networks to Enhance Clinician-Scientists' Participation in Research (R25 Clinical Trial Not Allowed) Apply for PAR 21 187 Funding Number: PAR 21 187 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Accelerating Medicines Partnership Autoimmune and Immune-Mediated Diseases: Technology and Analytic Cores (TACs) and Research Management Unit (RMU) (UC2 Clinical Trial Not Allowed) Apply for RFA AR 21 016 Funding Number: RFA AR 21 016 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Accelerating Medicines Partnership Autoimmune and Immune-Mediated Diseases: Disease Teams for Rheumatoid Arthritis, Lupus, Psoriatic Spectrum Diseases, and Sjgrens Syndrome (UC2 Clinical Trial Optional) Apply for RFA AR 21 015 Funding Number: RFA AR 21 015 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Effectiveness Trials for Post-Acute Interventions and Services to Optimize Longer-term Outcomes (R01 Clinical Trial Required) Apply for PAR 21 210 Funding Number: PAR 21 210 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Pilot Effectiveness Trials for Post-Acute Interventions and Services to Optimize Longer-term Outcomes (R34 Clinical Trial Required) Apply for PAR 21 211 Funding Number: PAR 21 211 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Innovative Programs to Enhance Research Training (IPERT) (R25 Independent Clinical Trial Not Allowed) Apply for PAR 21 196 Funding Number: PAR 21 196 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Mentoring Networks to Enhance Diversity in NIDCD's Extramural Research Workforce (R25 Clinical Trial Not Allowed) Apply for PAR 21 185 Funding Number: PAR 21 185 Agency: National Institutes of Health Category: Health Funding Amount: $250,000 |
| Pilot Projects Investigating Understudied G Protein-Coupled Receptors, Ion Channels, and Protein Kinases (R03 Clinical Trial Not Allowed) Apply for RFA RM 21 012 Funding Number: RFA RM 21 012 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Intramural - Extramural Collaboration for Drug Screening with Biofabricated 3-D Disease Tissue Models (UH2/UH3 Clinical Trial Not Allowed) Apply for RFA TR 21 015 Funding Number: RFA TR 21 015 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "RFA AG 22 010", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.